CNBCLean R·
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
The drug is a once-daily pill designed to block several forms of the RAS protein, which helps drive tumor growth in many pancreatic cancers.
Read at CNBC →
Business · 1 sources covering this
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
The drug is a once-daily pill designed to block several forms of the RAS protein, which helps drive tumor growth in many pancreatic cancers.
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/9ead3c80a9ab10448a5ab62ebba0441339694b55" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Revolution Medicines gets FDA nod for targeted pancreatic cancer drug"></iframe>
